Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,139.0
-18.1 (-0.57%)

 

  • STI Straits Times Index
    3,139.0
    -18.1 (-0.57%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,512.5
    -10.9 (-0.72%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,192.3
    -1,129.7 (-4.13%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,467.4
    -83.0 (-2.34%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,833.3
    285.3 (1.04%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,106.4
    4.7 (0.08%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,058.1M
  • Value: 970.5M
  • Rise: 151
  • Fall: 191
  • Unch: 419

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Thomson Medical0.088+0.003
Jiutian Chemical0.084-0.001
Sembcorp Marine0.104+0.001
Spackman0.005-
Accrelist Ltd0.072+0.015
Oceanus^0.036-
Abundance Intl0.040+0.001
ThaiBev0.655-0.005
SPH1.860+0.010
Rex Intl0.205-

World Indices

World Indices
Name Last Change
Nasdaq 14,837.0 +152.4
HSI 26,192.3 -1129.7
HSCEI 9,355.2 -483.8
Jakarta 6,106.4 +4.7
Nikkei 225 27,833.3 +285.3
SSE Comp 3,467.4 -83.0
Shanghai A 3,634.2 -87.0
Shanghai B 260.4 -3.4
KOSPI 3,224.9 -29.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

EMERGENT BIOSOLUTIONS INC EMERGENT BIOSOLUTIONS
Updated on 23 Jul 2021 (End of trading day)
Last (USD): 64.390 Change: +0.740 High: 64.700 Remarks: -
Change (%): +1.16 Low: 63.770
Open 64.390 Yesterday's Close 63.65
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 234,843 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 5.69370 Trailing EPS (USD) e 7.22770 NAV (USD) b 28.4181
PE a 11.309 Trailing PE f 8.909 Price / NAV b 2.2658
Dividend (USD) d - Cash In Hand (USD) g 10.2266 Issued & Paid-up Shares c 53,585,500
Dividend Yield (%) d - Price / Cash In Hand g 6.296 Treasury Shares h 1,200,000
Market Cap (M) 3,450.370 Enterprise Value (M) 3,793.070
Piotroski F Score 7 Exchange Code EBS Par Value ( $ ) n.a.
52 Weeks Volatility (%) 57.31 Free Float (%) 92.1
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 05 May 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 25 Feb 2019.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference EMERGENT BIOSOLUTIONS INC NYSE 3,450.370 11.309 8.909 2.2658 -
Industry Pharmaceuticals: Major NYSE 119,893.283 34.002 30.008 6.9934 2.722
Local Peer JOHNSON & JOHNSON NYSE 452,391.786 30.746 25.462 - 2.316
Local Peer ELI LILLY AND COMPANY NYSE 234,146.198 37.804 38.432 33.9408 1.209
Local Peer PFIZER INC NYSE 233,311.719 24.263 21.036 3.4001 3.651
Local Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 222,919.839 27.453 24.785 4.1249 2.105
Local Peer ABBVIE INC NYSE 208,749.542 45.819 41.060 15.2262 4.093
Local Peer MERCK & CO INC NYSE 196,335.932 27.782 27.936 7.2866 3.196
Local Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 160,859.820 24.963 23.929 17.4014 1.482
Local Peer BRISTOL-MYERS SQUIBB CO NYSE 152,666.776 - - 4.0597 2.705
Local Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 99,400.838 13.483 14.640 4.8467 5.237
Local Peer TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS NYSE 53,222.974 15.012 15.012 1.1378 4.556
Local Peer BIOHAVEN PHARMACEUTICAL HLDG CO LTD NYSE 8,232.499 - - -29.8302 -
Local Peer ORGANON & CO NYSE 7,554.777 3.498 3.498 1.5999 -
Other Local Peers ADC THERAPEUTICS SA (NYSE), ZYMEWORKS INC (NYSE), AMNEAL PHARMACEUTICALS INC (NYSE), LANNETT CO INC (NYSE)
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 180,409.933 56.013 45.052 12.5024 1.994
Global Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 130,768.620 9.316 9.316 1.6964 2.584
Global Peer WUXI APPTEC HKEx 488,644.646 147.229 102.572 11.6733 0.213
Global Peer ROYALTY PHARMA PLC NASDAQ 24,484.827 25.112 25.169 5.0151 0.476
Global Peer HANSOH PHARMA HKEx 163,752.978 56.727 56.727 7.7263 0.279
Global Peer VIATRIS INC NASDAQ 16,824.547 - - 0.7857 -
Global Peer INNOVENT BIO HKEx 111,206.812 - - 10.6830 -
Global Peer CANSINOBIO-B HKEx 91,173.316 - - 12.6829 -
Global Peer REPLIGEN CORP NASDAQ 11,525.553 192.330 144.864 7.4061 -
Global Peer CUREVAC NV NASDAQ 10,087.537 - - - -
Other Global Peers SINOPHARM (HKEx), HUTCHMED (HKEx), HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS (NASDAQ), LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS (NASDAQ), JUNSHI BIO (HKEx), HYGEIA HEALTH (HKEx), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), SH PHARMA (HKEx), REMEGEN-B (HKEx), CMS (HKEx), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), AKESO-B (HKEx), APELLIS PHARMACEUTICALS INC (NASDAQ), INNOCARE-B (HKEx), REATA PHARMACEUTICALS INC (NASDAQ), BAIYUNSHAN PH (HKEx), ALLAKOS INC (NASDAQ), IMMUNITYBIO INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), SIMCERE PHARMA (HKEx), CHINARES PHARMA (HKEx), CEREVEL THERAPEUTICS HLDGS INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), TRAD CHI MED (HKEx), NEKTAR THERAPEUTICS (NASDAQ), CHINAGRANDPHARM (HKEx), DICERNA PHARMACEUTICALS INC. (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), OPKO HEALTH INC (NASDAQ), HENLIUS (HKEx), CSTONE PHARMA-B (HKEx), EVEREST MED-B (HKEx), ERASCA INC (NASDAQ), CARSGEN-B (HKEx), SSY GROUP (HKEx), ATEA PHARMACEUTICALS INC (NASDAQ), OCUMENSION-B (HKEx), QUANTERIX CORPORATION (NASDAQ), HEPALINK (HKEx), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), ANTENGENE-B (HKEx), UNITED LAB (HKEx), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), TONGRENTANGCM (HKEx), NRX PHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), Kimia Farma Tbk. (IDX), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), KRONOS BIO INC (NASDAQ), BROOKLYN IMMUNO THERAPEUTICS INC (NYSE American), SCICLONE PHARMA (HKEx), GENERATION BIO CO (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), IMMUNOTECH-B (HKEx), CULLINAN ONCOLOGY INC (NASDAQ), PETIQ INC (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), CKLIFE SCIENCES (HKEx), KINIKSA PHARMACEUTICALS LTD (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), ANNOVIS BIO INC (NYSE American), OCULAR THERAPEUTIX INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), SHINEWAY PHARM (HKEx), GH RESEARCH PLC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), POINT BIOPHARMA GLOBAL INC (NASDAQ), ANNEXON INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), PRAXIS PRECISION MEDICINES INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), ZHAOKE OPHTH-B (HKEx), ORIC PHARMACEUTICALS INC (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), EVOLUS INC (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), HUA MEDICINE-B (HKEx), VERU INC (NASDAQ), AC IMMUNE SA (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), WEREWOLF THERAPEUTICS INC (NASDAQ), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), ALZAMEND NEURO INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), Soho Global Health Tbk. (IDX), CLENE INC (NASDAQ), PHARVARIS NV (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), IGBB (Bursa), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), RACE ONCOLOGY LTD (ASX), PROVENTION BIO INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), BEYONDSPRING INC (NASDAQ), BIOMEA FUSION INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), GRITSTONE BIO INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), ATHENEX INC (NASDAQ), DAWNRAYS PHARMA (HKEx), PYC THERAPEUTICS LIMITED (ASX), 89BIO INC (NASDAQ), AFT PHARMACEUTICALS LTD (ASX), FUSION PHARMACEUTICALS INC (NASDAQ), DURECT CORP (NASDAQ), GAMIDA CELL LTD (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), BSTEAD (Bursa), VECTIVBIO HLDG AG (NASDAQ), ANGION BIOMEDICA CORP (NASDAQ), TOT BIOPHARM-B (HKEx), IMPEL NEUROPHARMA INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), SOL GEL TECHNOLOGIES LTD (NASDAQ), PHARMA (Bursa), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), VINCERX PHARMA INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), FUSEN PHARM (HKEx), OVID THERAPEUTICS INC (NASDAQ), MUSTANG BIO INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), NEXIMMUNE INC (NASDAQ), IMMUNIC INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), TRICIDA INC (NASDAQ), OBSEVA SA (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), IP (SET), CH BIOTECH SER (HKEx), ONCTERNAL THERAPEUTICS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), GENPREX INC (NASDAQ), POLYPID LTD (NASDAQ), IMARA INC (NASDAQ), ZHONGZHIPHARM (HKEx), VYNE THERAPEUTICS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), NOXOPHARM LTD (ASX), LOGICBIO THERAPEUTICS INC (NASDAQ), RECCE PHARMACEUTICALS LTD (ASX), AQUESTIVE THERAPEUTICS INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), NOVAN INC (NASDAQ), IX Biopharma (SGX), ENTERA BIO LTD (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), EYENOVIA INC (NASDAQ), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), PROPHASE LABS INC (NASDAQ), CRESO PHARMA LTD (ASX), GALECTO INC (NASDAQ), Merck Tbk. (IDX), MEDIWOUND LTD (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), YUMANITY THERAPEUTICS INC (NASDAQ), NEW RAY MEDIC (HKEx), CHARMACY PHAR (HKEx), APTORUM GROUP LIMITED (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), GRAYBUG VISION INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), KOTRA (Bursa), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), Phapros Tbk. (IDX), DARE BIOSCIENCE INC (NASDAQ), SYNAPTOGENIX INC (NASDAQ), PAK FAH YEOW (HKEx), NC HEALTHCARE (HKEx), Hyphens Pharma (SGX), EDESA BIOTECH INC (NASDAQ), MODERN CHI MED (HKEx), UNIVERSE PHARMACEUTICALS INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), NOVA (Bursa), EXOPHARM LTD (ASX), INHIBIKASE THERAPEUTICS INC (NASDAQ), BIOHLDG (Bursa), MANNATECH INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), AGEX THERAPEUTICS INC (NYSE American), ASSERTIO HOLDINGS INC (NASDAQ), INVION LTD (ASX), BAUDAX BIO INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), NEP INTERLONG (HKEx), ACURX PHARMACEUTICALS INC (NASDAQ), WAI YUEN TONG (HKEx), VIRIOS THERAPEUTICS INC (NASDAQ), MEDLAB CLINICAL LIMITED (ASX), CNS PHARMACEUTICALS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), PALLA PHARMA LTD (ASX), TELIGENT INC NEW (NASDAQ), TBG DIAGNOSTICS LTD (ASX), TREVI THERAPEUTICS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), PAINREFORM LTD (NASDAQ), EXTRAWELL PHAR (HKEx), PURAPHARM (HKEx), ONCOSIL MEDICAL LIMITED (ASX), ACER THERAPEUTICS INC (NASDAQ), TIMBER PHARMACEUTICALS INC (NYSE American), SANAI HEALTH GP (HKEx), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), PANBELA THERAPEUTICS INC (NASDAQ), NLS PHARMACEUTICS LTD (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), JCT (SET), SUNZEN (Bursa), PETROS PHARMACEUTICALS INC (NASDAQ), PHARMAXIS (ASX), ACRUX (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), IMMURON LIMITED (ASX), TALI DIGITAL LIMITED (ASX), TITAN PHARMACEUTICAL INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), VIRPAX PHARMA INC (NASDAQ), SUDA PHARMACEUTICALS LTD (ASX), ISLAND PHARMACEUTICALS LTD (ASX), SINOLIFE UTD (HKEx), PASHUN INT'L (HKEx), FIJI KAVA LTD (ASX), CELLMID LIMITED (ASX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.710
+1.11 %
10 Days -+4.650
+7.78 %
20 Days -+1.710
+2.73 %
Medium Term Return 3 Months -+0.400
+0.63 %
6 Months --41.980
-39.47 %
1 Year --30.390
-32.06 %
Long Term Return 2 Years -+20.820
+47.79 %
3 Years -+11.400
+21.51 %
5 Years -+33.420
+107.91 %
Annualised Return Annualised --
+15.76 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 55.069 - 137.610 Change From 1 Year Low +9.321 % Change From 1 Year Low (%) +16.93
Change From 1 Year High -73.220 % Change From 1 Year High (%) -53.21
2 Years Range 39.110 - 137.610 Change From 2 Years Low +25.280 % Change From 2 Years Low (%) +64.64
Change From 2 Years High -73.220 % Change From 2 Years High (%) -53.21
5 Years Range 24.470 - 137.610 Change From 5 Years Low +39.920 % Change From 5 Years Low (%) +163.14
Change From 5 Years High -73.220 % Change From 5 Years High (%) -53.21
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives; Antibody Therapeutics; Devices; and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri in May 1998 and is headquartered in Gaithersburg, MD.

Historical Price Data

Date Open High Low Close Volume VWAP
23 Jul 2021 64.390 64.700 63.770 64.390 234,843 -
22 Jul 2021 65.700 66.280 63.550 63.650 284,794 -
21 Jul 2021 65.250 66.180 63.730 66.050 672,076 -
20 Jul 2021 63.690 65.760 63.250 65.120 897,366 -
19 Jul 2021 61.000 63.700 60.490 63.680 522,863 -
16 Jul 2021 61.160 63.829 60.500 62.430 585,586 -
15 Jul 2021 58.040 60.840 57.905 60.430 476,841 -
14 Jul 2021 58.360 59.260 57.850 58.590 314,356 -
13 Jul 2021 59.020 59.580 57.820 57.920 412,617 -
12 Jul 2021 60.380 60.835 59.510 59.740 284,997 -
09 Jul 2021 59.440 60.900 59.010 60.150 380,864 -
08 Jul 2021 60.270 60.470 58.230 59.070 595,987 -
07 Jul 2021 61.790 62.000 60.860 61.530 617,376 -
06 Jul 2021 63.170 63.470 60.890 61.670 370,142 -
02 Jul 2021 64.000 65.610 62.870 63.760 522,071 -
01 Jul 2021 63.080 64.120 62.720 64.030 449,355 -
30 Jun 2021 63.660 63.949 62.920 62.990 873,305 -
29 Jun 2021 62.680 64.170 62.080 64.000 1,178,889 -
28 Jun 2021 64.040 64.166 62.030 62.680 478,165 -
25 Jun 2021 62.480 63.460 62.310 63.370 2,860,650 -
24 Jun 2021 60.450 62.130 60.180 61.850 420,850 -
23 Jun 2021 58.720 60.290 58.700 60.050 446,485 -
Summary
Current 2 Weeks
(12 Jul 2021 to 23 Jul 2021)
60.380 66.280 57.820 64.390 4,686,339 -
Previous 2 Weeks
(25 Jun 2021 to 09 Jul 2021)
62.480 66.280 57.820 60.150 8,326,804 -
4 Weeks from
(27 May 2021 to 24 Jun 2021)
57.420 66.280 56.585 61.850 15,016,808 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.